AMENDED AND RESTATED NEWS RELEASE
This amended and restated news release filed on February 27, 2023 reproducesthe news release filed on February 2, 2023, except that this amended andrestated news release includes the addition of the term of the agreement and theannual fees to be paid for the various services under the agreement.
PulseIR to power Empower Clinics with automated tools to delivermobilized, data-driven activation and communication channels
VANCOUVER, B.C.: February 27, 2023 – EMPOWER CLINICS INC (CSE:EPW) (OTCPINK:EPWCF) (“Empower” or the “Company”) a life sciences healthcare company – servingpatients through medical centers, a medical device company and the application of clinicalstudies that leverages it’s high complexity medical diagnostics laboratory – today announcedthat it signed a deal with PulseIR, a wholly-owned subsidiary of Fobi AI Inc, to deliverpersonalized, automated, and data-driven mobile investor relations (IR) solutions to theirexisting and potential shareholders.
Investor relations (IR) platforms must be able to fully deliver content and mobilization thatpublic companies need to connect their stories, drive ROI, and gain traction in a digital market.PulseIR, which supports Fobi’s IR platform Investor Pass, delivers a new experience ofpersonalized engagement through real-time, mobile lock screen communication. PulseIR willdeliver a data-driven and digital approach to Empower’s IR, directly to followers and investors,generating alerts, company news, events, and more. The agreement is for a one-year termwith the annual fees for the various services set at $120,000.00 CAD.
“This partnership with PulseIR provides a platform to improve our IR strategy and results,”stated Steven McAuley, Chairman and CEO of Empower Clinics. “Better understanding ourinvestors and having a new means of direct and personalized communication will make all thedifference in how we acquire, engage, and retain our investors and followers. Empower pridesitself on using state-of-the-art technology and this agreement with PulseIR helps us bringnew capability to our investor relations programs.”
This press release is available on the Empower Clinics Verified Forum on AGORACOM forshareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company with multi-disciplinary clinics, an at-homemedical testing device company and state-of-the-art medical diagnostics laboratories. With agrowing presence in the U.S. and Canada. Empower is a leader in integrated healthcare anddiagnostics solutions and is reshaping the model for patient-first wellness.
About Fobi
Founded in 2017 in Vancouver, Canada, Fobi is a leading AI and data intelligence companythat provides businesses with real-time applications to digitally transform and future-prooftheir organizations. Fobi enables businesses to action, leverage, and monetize their customerdata by powering personalized and data-driven customer experiences and drives digitalsustainability by eliminating the need for paper and reducing unnecessary plastic waste atscale.
Fobi works with some of the largest global organizations across retail & CPG, insurance, sports& entertainment, casino gaming, and more. Fobi is a recognized technology and dataintelligence leader across North America and Europe, and is the largest data aggregator inCanada’s hospitality & tourism industry.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Media:
Steven McAuley CEO
s.mcauley@empowerclinics.com
+1 855-855-9058
Investors:
Tamara Mason
Business Development &
Communications
t.mason@empowerclinics.com
+1 855-855-9058
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements” or “forward-looking information”(collectively “forward looking statements”) within the meaning of applicable Canadian securities laws.All statements, other than statements of historical fact, are forward-looking statements and are basedon expectations, estimates and projections as at the date of this news release. Forward-lookingstatements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”,”intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similarwords, or information that certain events or conditions “may” or “will” occur. Forward-lookingstatements in this news release include statements regarding: that Pulse IR will deliver a new datadriven and digital approach to Empower’s IR, generating alerts, company news and events. Suchforward-looking statements are based on assumptions known to management at this time, and aresubject to risks and uncertainties that may cause actual results, performance or developments to differmaterially from those contained in the forward-looking statements, including: that the Company maynot be able to obtain adequate financing to pursue its business plan; general business, economic,competitive, political and social uncertainties; and other factors beyond the Company’s control. Noassurance can be given that any of the events anticipated by the forward-looking statements will occuron the terms or in the time expected, or at all, or, if they do occur, what benefits the Company willobtain from them. Readers are cautioned not to place undue reliance on the forward-looking statementsin this release, which are qualified in their entirety by these cautionary statements. The Company isunder no obligation, and expressly disclaims any intention or obligation, to update or revise any forwardlooking statements in this release, whether as a result of new information, future events or otherwise,except as expressly required by applicable securities laws.